US court upholds Sotheby’s poison pill, rejects hedge fund’s bid


BOSTON: A US court rejected activist hedge fund manager Daniel Loeb’s bid to force auction house Sotheby’s to remove its shareholder rights plan, which limits the amount of stock he can buy.

Delaware Chancery Court Judge Donald Parsons ruled late on Friday that he would not overturn Sotheby’s so-called poison pill, which blocks activist investors from buying more than 10% of the company’s stock while passive investors can buy 20%.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Business , sotheby

   

Next In Business News

Wall Street set for higher open as rate-cut hopes linger
Shell in talks to sell Malaysia fuel stations to Saudi Aramco, sources say
Court Of Appeal rules in favour of SC in insider trading case
EPF buys more shares in QL Resources, raising stake to 5.01%
MGRC and Twistcode Technologies collaborate to develop advanced bioinformatics platform
Ringgit trims earlier gains to end slightly lower against US dollar
Ho Hup disposes of Bukit Jalil land for RM110mil
Perodua eyes 79% export surge to 1,960 units this year
Favelle Falco secures RM39.2mil contracts for offshore, tower cranes
RHB Islamic International Asset Management appoints Najman Isa as CEO

Others Also Read